According to a report by Research and Markets, the global medical plastics market was valued at US$24.672 billion in 2019 and is expected to reach US$44.67 billion by 2027, with a compound annual growth rate of 7.7% from 2020 to 2027. Behind the interesting data is a significant and long-term development opportunity for the field created by the perfect "storm effect" of many factors. For example, there are still short-term and long-term supply shortages in the supply of key medical devices around the world. In order to solve the local production gap in each country, the localisation trend of medical manufacturing is unstoppable. With the coronavirus continuing to affect health conditions and the rapidly ageing population, the demand for medical plastics is set to rise.
How easy is it to enter and scale up in the blood collection tube market? On 24 February 2022, from 15:15 to 16:15 (Singapore time), Manson Zhang, a senior expert in Husky's Asia-Pacific medical business and solutions, will discuss the trends and opportunities in a Ringier live broadcast. Manson will focus on the market trends and regulatory framework, starting from the design specifications and requirements of blood collection tubes. He will also discuss the feasibility of entering the market of blood collection tube manufacturing.
Sign up for FREE at https://bit.ly/3npwlSe
About the Speaker
Mr Manson Zhang has 10 years’ experience in injection moulding, having joined Husky as a product specialist for aftermarket tooling, followed by a business advisor role for injection moulding systems for six years, covering the North Asia region.
With strong knowledge in plastic injection moulding, Manson supports customers and prospective customers on a variety of application development projects, as well as business case analysis. Playing a key role in Husky’s Asia team, he has excellent knowledge of end-to-end application development and helps customers to build business model base in specific market segments, while working together with downstream and industry partners to provide turnkey packaging solutions.
Now based in Husky’s Asian headquarters in Shanghai, Mason supports the medical system business for Asia Pacific, working with existing and prospective customers looking to expand their business, or enter medical manufacturing, providing both technical and business solutions.
About Husky Injection Molding Systems Ltd.
As the largest brand-name supplier of injection moulding equipment and services to the plastics industry, Husky Injection Molding Systems Ltd. is composed of engineers, designers, innovators, material and software specialists, and problem solvers. Team Husky comprises more than 4,300 dedicated people worldwide, focused on building success and profitability for our customers, who operate in over 140 countries.
The headquarters and main manufacturing facilities are located in Canada, with additional manufacturing facilities in the U.S., Luxembourg, Switzerland, China and the Czech Republic. Plus, three technical centres in Japan, Luxembourg and Shanghai, as well as a global network of locations throughout the United States, Latin America, Europe, the Middle East, Africa, Asia-Pacific, China, Australia and India.
Husky builds, installs and supports the world’s most comprehensive range of injection moulding systems and equipment, including machines, moulds, hot runners, auxiliaries and integrated systems. And Husky backs them with strong warranties and available extended protection plans, as well as personalised assistance from 600 representatives in 40 service and sales offices.
For webinar inquiry, please contact:
Brandon Lin / Ringier Trade Media Ltd.
Copyright (c) Ringier Trade.com. Copyright (c) Ringier Trade Media Ltd. (c) 2021.
All rights reserved. Reproduction in whole or part in any form or medium without express written permission is not allowed.
Ringier Trade .com (c) Ringier Trade Media Ltd., accept no responsibility or liability for any information provided by any third party on this website.